Literature DB >> 33179785

Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients.

Jara Valtueña1, Gerardo Martínez-García2, Daniel Ruiz-Sánchez1, María Garayar-Cantero1, Carlos Dueñas3, Ali Hadi4, Suhail Hadi4, Ángel Aguado-García1, José M Prieto de Paula3, Pilar Manchado-López1.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a systemic multi-organ viral illness. Previous studies have found that many patients had a procoagulant state and/or severe hypoxemia with relatively well-preserved lung mechanics. Mechanisms underlying the damage to vascular tissues are not well-elucidated yet. Histological data in COVID-19 patients are still limited and are mainly focused on post-mortem analysis. Given that the skin is affected by COVID-19 and the relative ease of its histological examination, we aimed to examine the histology of skin lesions in COVID-19 patients to better understand the disease's pathology.
METHODS: Five skin lesions from COVID-19 adult patients were selected for a deep histological tissue examination.
RESULTS: A strong vasculopathic reaction pattern based on prominent vascular endothelial and myointimal cell growth was identified. Endothelial cell distortion generated vascular lumen obliteration and striking erythrocyte and serum extravasation. Significant deposition of C4d and C3 throughout the vascular cell wall was also identified. A regenerative epidermal hyperplasia with tissue structure preservation was also observed.
CONCLUSIONS: COVID-19 could comprise an obliterative microangiopathy consisting on endothelial and myointimal growth with complement activation. This mechanism, together with the increased vascular permeability identified, could contribute to obliteration of the vascular lumen and hemorrhage in COVID-19. Thus, anticoagulation by itself could not completely reverse vascular lumen obliteration, with consequent increased risk of hemorrhage. Findings of this study could contribute to a better understanding of physiopathological mechanisms underlying COVID-19 on living patients and could help further studies find potential targets for specific therapeutic interventions in severe cases.
© 2020 the International Society of Dermatology.

Entities:  

Year:  2020        PMID: 33179785     DOI: 10.1111/ijd.15300

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  Recrudescence of livedoid vasculopathy induced by COVID-19.

Authors:  Flávia de Oliveira Valentim; Giuliane Minami Tsutsui; Hélio Amante Miot
Journal:  Int J Dermatol       Date:  2021-02-02       Impact factor: 3.204

Review 2.  [COVID-19 and skin manifestations: overview of current literature].

Authors:  Kristin Lange; Maja Matthies; Parnian Firouzi-Memarpuri; Bernhard Homey
Journal:  Hautarzt       Date:  2022-03-07       Impact factor: 0.751

Review 3.  Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.

Authors:  Santiago Moreno; Bernardino Alcázar; Carlos Dueñas; Juan González Del Castillo; Julián Olalla; Antonio Antela
Journal:  Drug Des Devel Ther       Date:  2022-03-25       Impact factor: 4.162

Review 4.  Complement activation in COVID-19 and targeted therapeutic options: A scoping review.

Authors:  Endry Hartono Taslim Lim; Rombout Benjamin Ezra van Amstel; Vieve Victoria de Boer; Lonneke Alette van Vught; Sanne de Bruin; Matthijs Christian Brouwer; Alexander Petrus Johannes Vlaar; Diederik van de Beek
Journal:  Blood Rev       Date:  2022-07-30       Impact factor: 10.626

5.  Acral edema during the COVID-19 pandemic.

Authors:  Jara Valtueña; Daniel Ruiz-Sánchez; Victor Volo; Pilar Manchado-López; María Garayar-Cantero
Journal:  Int J Dermatol       Date:  2020-07-01       Impact factor: 3.204

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.